Malin Life Sciences Holdings Ltd, Ten Percent Owner Other at Poseida Therapeutics, Inc. (PSTX), bought 758,752 shares at $7.21 ($5.5M) on 2021-11-17, disclosed to the SEC on 2021-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.17 | 27,680 | $198K | 3.6% |
| 2 | $7.17 | 27,680 | $198K | 3.6% |
| 3 | $7.21 | 280,384 | $2.0M | 37.0% |
| 4 | $7.21 | 280,384 | $2.0M | 37.0% |
| 5 | $7.18 | 71,312 | $512K | 9.4% |
| 6 | $7.18 | 71,312 |
| $512K |
| 9.4% |
| Total | $7.20 avg | 758,752 | $5.5M | 100% |
| Filing → |
| PSTX | BUY | 2021-12-02 | $673K | — | Filing → |
| PSTX | BUY | 2021-11-29 | $531K | — | Filing → |
| PSTX | BUY | 2021-11-23 | $363K | — | Filing → |